Kyndryl (NYSE:KD) Upgraded to “Buy” at Wall Street Zen

Wall Street Zen upgraded shares of Kyndryl (NYSE:KD) from a hold rating to a buy rating in a research note published on Sunday morning.

A number of other equities analysts also recently commented on the stock. Susquehanna lowered their target price on shares of Kyndryl from $35.00 to $16.00 and set a “positive” rating for the company in a research note on Friday, February 13th. Oppenheimer reaffirmed a “market perform” rating on shares of Kyndryl in a report on Monday, February 9th. Zacks Research cut Kyndryl from a “hold” rating to a “strong sell” rating in a research report on Wednesday, February 18th. Scotiabank began coverage on Kyndryl in a research note on Tuesday, January 27th. They set an “outperform” rating for the company. Finally, JPMorgan Chase & Co. cut shares of Kyndryl from an “overweight” rating to an “underweight” rating and set a $16.00 price objective on the stock. in a report on Monday, February 9th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, Kyndryl currently has an average rating of “Hold” and an average price target of $29.00.

Kyndryl Stock Performance

Shares of KD opened at $12.53 on Friday. Kyndryl has a 1 year low of $10.10 and a 1 year high of $44.20. The stock has a market capitalization of $2.82 billion, a PE ratio of 11.93 and a beta of 1.85. The company has a debt-to-equity ratio of 1.75, a quick ratio of 0.86 and a current ratio of 0.86. The stock has a 50-day simple moving average of $22.97 and a 200-day simple moving average of $26.78.

Kyndryl (NYSE:KD) last issued its earnings results on Monday, February 9th. The company reported $0.52 earnings per share for the quarter, missing the consensus estimate of $0.60 by ($0.08). Kyndryl had a net margin of 1.65% and a return on equity of 25.91%. The firm had revenue of $3.86 billion during the quarter, compared to analyst estimates of $3.89 billion. During the same period last year, the business earned $0.51 EPS. The firm’s revenue was up .6% compared to the same quarter last year. On average, analysts predict that Kyndryl will post 0.73 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Kyndryl news, SVP Vineet Khurana sold 6,641 shares of Kyndryl stock in a transaction that occurred on Friday, December 5th. The stock was sold at an average price of $26.69, for a total value of $177,248.29. Following the transaction, the senior vice president directly owned 59,708 shares in the company, valued at approximately $1,593,606.52. This trade represents a 10.01% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.90% of the company’s stock.

Institutional Trading of Kyndryl

Several hedge funds and other institutional investors have recently made changes to their positions in KD. Assetmark Inc. lifted its position in Kyndryl by 75.3% in the second quarter. Assetmark Inc. now owns 775 shares of the company’s stock valued at $33,000 after purchasing an additional 333 shares during the period. Los Angeles Capital Management LLC purchased a new position in shares of Kyndryl during the 4th quarter worth approximately $29,000. Employees Retirement System of Texas acquired a new stake in shares of Kyndryl in the 2nd quarter valued at approximately $49,000. Smartleaf Asset Management LLC lifted its holdings in shares of Kyndryl by 192.0% in the 3rd quarter. Smartleaf Asset Management LLC now owns 1,171 shares of the company’s stock valued at $35,000 after buying an additional 770 shares during the period. Finally, Quarry LP acquired a new position in Kyndryl during the fourth quarter worth $31,000. Hedge funds and other institutional investors own 71.53% of the company’s stock.

Key Headlines Impacting Kyndryl

Here are the key news stories impacting Kyndryl this week:

• Positive Sentiment: Kyndryl opened a Cyber Defense Operations Center in Bengaluru to combine network and security operations, which could strengthen its managed security services revenue and operational capability for large enterprise customers. Read More.
• Neutral Sentiment: Numerous plaintiff law firms are soliciting Kyndryl investors and reminding holders of an April 13, 2026 deadline to seek lead‑plaintiff status in class actions covering Aug. 7, 2024–Feb. 9, 2026. This increases visibility of litigation but is procedural until courts appoint lead plaintiffs and complaints proceed. Read More.
• Negative Sentiment: Kyndryl filed amended quarterly and annual reports disclosing that its disclosure controls and internal control over financial reporting were ineffective for multiple quarters in 2025. Material internal‑control weaknesses raise risk of further restatements, regulatory scrutiny and investor lawsuits. Read More.
• Negative Sentiment: At least one securities class action alleges that a series of disclosures (late filing, “tone at the top” issues, exec departures and an SEC request) triggered a ~55% share plunge last week; that complaint increases litigation and settlement risk for KD. Read More.
• Negative Sentiment: Analyst action: Zacks moved KD to a “Strong Sell” ranking, reflecting near‑term concern among sell‑side models and amplifying downward pressure from sentiment shifts. Read More.

Kyndryl Company Profile

Kyndryl (NYSE: KD) is a global managed infrastructure services provider formed in November 2021 through the spin-off of IBM’s Managed Infrastructure Services business. The company designs, builds, manages and modernizes critical information technology systems for enterprises worldwide. Kyndryl’s core offerings include cloud migration and management, network and edge computing solutions, digital workplace services and IT resiliency and security capabilities.

With a workforce of approximately 90,000 professionals and operations in more than 60 countries, Kyndryl serves clients across a broad range of industries, including financial services, telecommunications, healthcare, manufacturing and retail.